Stay updated on Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The page revision label was updated from v3.6.0 to v3.6.2, indicating a small update to the page software or documentation. No study content or user-facing information was altered.
    Difference
    0.1%
    Check dated 2026-06-26T22:55:16.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Added new navigation/help sections—How to Read a Study Record, Common Questions, and How to Join a Study—and a recruitment note stating No longer looking for participants. The Intervention / Treatment heading was normalized to Intervention/Treatment and the page revision stamp updated to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T13:34:21.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Revision: v3.5.5 indicates a minor page update. It does not change the clinical trial data, eligibility criteria, or how the page is used.
    Difference
    0.1%
    Check dated 2026-06-05T09:58:32.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    - Revision indicator updated from v3.5.3 to v3.5.4, reflecting a new build of the page.
    Difference
    0.1%
    Check dated 2026-05-15T05:44:38.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The site’s release/version indicator for the ClinicalTrials.gov study page has been updated from v3.5.2 to v3.5.3, reflecting a platform or content release change rather than any modification to the study details.
    Difference
    0.1%
    Check dated 2026-04-24T05:45:31.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:28:51.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial page.